Advaxis and Sellas Life Sciences Group, two companies that have pursued different ways of prompting the body’s immune system to fight cancer, are now hoping that combining their efforts will lead to a more precise treatment. The agreement between the companies calls for Princeton, NJ-based Advaxis (NASDAQ: ADXS) to license to Sellas its technology for […]
What Our Clients Say
[ssba_hide]
[testimonials category="Testimonial" random=true limit="1"]
Press Releases and Whitepapers
Industry News & Articles
- India’s Paytm wins approval to resume payments growth
- Lending fintech SoLo Funds faces class-action lawsuit
- EVTOL startups just got a big lift from the US government
- LinkedIn confirms the ‘follower purge’ was just a bug that’s now resolved
- One Zero could be raising $100M
- Farewell to Foursquare’s app
- SEC fines four companies $7 million for ‘misleading cyber disclosures’ regarding SolarWinds hack
- Artiphon’s new Orba instrument can sample sounds live
Sample Relationships
[logo-carousel id=relationships]
Notables
[logo-carousel id=notables]